The Effect of Toxoplasmosis on Pregnant Women and Its Diagnosis by “VIDAS Test of IgG Avidity”
Toxoplasmosis is well known as a cause of infection in pregnant women. Although many serological methods are available, diagnosis of early Toxoplasmosis may be extremely difficult. Toxoplasmosis is typically diagnosed during pregnancy via testing of maternal serum for IgM and IgG anti-Toxoplasma antibodies. Toxoplasmosis is normally asymptomatic, but it can have serious effects in immune-deficient individuals. Because avidity increases over time during infection, determining specific IgG avidity allows for more precise dating. Long-term IgM persistence makes it difficult to distinguish between acute and chronic infection. Seventy-six women were tested for VIDAS lgM, lgG antibodies, and VIDAS toxo-IgG avidity during the first 16 weeks of pregnancy. Low avidity antibodies were found in two (33.3%) of the six IgM-positive sera and four (11.11%) of the IgG-positive sera. Low avidity was noticed in 2 (3.27%) of the 61 sera that were negative for IgM. The low avidity indicates a recent infection, whereas high avidity in 4 (50%) of the 6 positive IgM and 24 (74.74%) of the 33 positive IgG indicates a long-ago infection. These conclusions emphasise the importance of using “VIDAS IgG avidity” in conjunction with the VIDAS IgM and IgG assays to offer to prove the presence of acute infection from a single serum sample for pregnant women
Alday P.H. and J.S. Doggett (2017). Drugs in development for toxoplasmosis: Advances challenges and current status. Drug Des Devel. Ther., 11: 273-293
Agmas, B., Tesfaye, R. and D.N. Koye (2015). Seroprevalence of Toxoplasma gondii infection and associated risk factors among pregnant women in Debre Tabor, Northwest Ethiopia. BMC Research Notes, 8(1): 1-7.
Andiappan, H., Nissapatorn, V., Sawangjaroen, N., Chemoh, W., Lau, Y.L., Kumar, T. and V. Chandeying (2014). Toxoplasma infection in pregnant women: A current status in Songklanagarind hospital, southern Thailand. Parasites & Vectors, 7(1): 1-7.
Alvarado-Esquivel, C., Estrada-Martínez, S. and O. Liesenfeld (2011). Toxoplasma gondii infection in workers occupationally exposed to unwashed raw fruits and vegetables: A case control seroprevalence study. Parasites & Vectors, 4(1): 1-7.
Berredjem, H., Aouras, H., Benlaifa, M., Becheker, I. and M.R. Djebar (2017). Contribution of IgG avidity and PCR for the early diagnosis of toxoplasmosis in pregnant women from the North-Eastern region of Algeria. African Health Sciences, 17(3): 647-656..
Cortina-Borja, M., Tan, H.K., Wallon, M., Paul, M., Prusa, A., Buffolano, W. and European Multicentre Study on Congenital Toxoplasmosis (EMSCOT) (2010). Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: An observational prospective cohort study. PLoS Medicine, 7(10): e1000351.
Foroutan-Rad, M., Khademvatan S., Majidiani H., Aryamand, S., Rahim, F. and A.S. Malehi (2016). Seroprevalence of Toxoplasma gondii in the Iranian pregnant women: A systematic review and meta-analysis. Acta Trop., 158: 160-169.
Gutiérrez-Zufiaurre, N., Sánchez-Hernández, J., Muñoz, S., Marín, R., Delgado, N., Sáenz, M.C. and, J.A. García-Rodríguez (2004). Seroprevalence of antibodies against Treponema pallidum, Toxoplasma gondii, rubella virus, hepatitis B and C virus, and HIV in pregnant women. Enfermedadesinfecciosas y microbiologiaclinica, 22(9): 512-516
Kamani, J., Mani, A.U. and G.O. Egwu (2010). Seroprevalence of Toxoplasma gondii infection in domestic sheep and goats in Borno state, Nigeria. Tropical Animal Health and Production, 42: 793-797.
Kompalic-Cristo, A., Frotta, C., Suárez-Mutis, M., Fernandes, O. and C. Britto (2007). Evaluation of a real-time PCR assay based on the repetitive B1 gene for the detection of Toxoplasma gondii in human peripheral blood. Parasitology Research, 101(3): 619-625.
Mwambe, B., Mshana, S.E., Kidenya, B.R., Massinde, A.N., Mazigo, H.D., Michael, D. and U. Groß (2013). Seroprevalence and factors associated with Toxoplasma gondii infection among pregnant women attending antenatal care in Mwanza, Tanzania. Parasites & Vectors, 6(1): 1-5.
Petersen, E., Pollak, A., and I. Reiter-Owona (2001). Recent trends in research on congenital toxoplasmosis. International Journal for Parasitology, 31(2): 115-144.
Pomares, C. and J.G. Montoya (2016). Laboratory diagnosis of congenital toxoplasmosis. Journal of Clinical Microbiology, 54(10): 2448-2454.
Rahbari, A.H., Keshavarz, H., Shojaee, S., Mohebali, M. and M. Rezaeian (2012). IgG avidity ELISA test for diagnosis of acute toxoplasmosis in humans. The Korean Journal of Parasitology, 50(2): 99-102.
Ramzan, M., Akhtar, M., Muhammad, F., Hussain, I., Hiszczyńska-Sawicka, E., Haq, A.U. and M. AHafeez (2009). Seroprevalence of Toxoplasma gondii in sheep and goats in Rahim Yar Khan (Punjab), Pakistan. Tropical Animal Health and Production, 41(7): 1225-1229.
Suzuki, L.A., Rocha, R.J. and C.L. Rossi (2001). Evaluation of serological markers for the immunodiagnosis of acute acquired toxoplasmosis. Journal of Medical Microbiology, 50(1): 62-70.
Thiébaut, R., Leproust, S., Chêne, G. and R. Gilbert (2007). Effectiveness of prenatal treatment for congenital toxoplasmosis: A meta-analysis of individual patients’ data. The Lancet, 369(9556): 115-122.